|Positive WB detected in||mouse heart tissue, HEK-293 cells|
|Positive IHC detected in||human lung cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Western Blot (WB)||WB : 1:500-1:1000|
|Immunohistochemistry (IHC)||IHC : 1:100-1:400|
|Sample-dependent, check data in validation data gallery|
10646-1-AP targets HIF1AN in WB, IHC applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||HIF1AN fusion protein Ag0997|
|Full Name||hypoxia inducible factor 1, alpha subunit inhibitor|
|Calculated molecular weight||40 kDa|
|GenBank accession number||BC007719|
|Gene ID (NCBI)||55662|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
HIF1AN(Hypoxia-inducible factor 1-alpha inhibitor) is also named as FIH1. It is identified as a molecular oxygen-dependent dioxygenase that blunts the transcriptional activity of HIF and has also been implicated in HIF-dependent and -independent hypoxia responses(PMID:20720525). Structural studies indicate that an FIH-1 homodimer forms in solution and is essential for FIH-1 activity(PMID:16154531).
Am J Cancer Res
Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development.
Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds.